Email Alerts
RSS
Volume 37 Issue 12
Dec.  2021
Turn off MathJax
Article Contents
Article Navigation >  CHINESE JOURNAL OF BURNS AND WOUNDS  > 2021  >  37(12): 1158-1165
Wu JF,Hong XD,Jin J,et al.Effects of N-trimethyl chitosan-recombinant tissue factor pathway inhibitor complex on avulsion flap with roll compaction in rat[J].Chin J Burns,2021,37(12):1158-1165.DOI: 10.3760/cma.j.cn501120-20200914-00409.
Citation: Wu JF,Hong XD,Jin J,et al.Effects of N-trimethyl chitosan-recombinant tissue factor pathway inhibitor complex on avulsion flap with roll compaction in rat[J].Chin J Burns,2021,37(12):1158-1165.DOI: 10.3760/cma.j.cn501120-20200914-00409.
shu

Effects of N-trimethyl chitosan-recombinant tissue factor pathway inhibitor complex on avulsion flap with roll compaction in rat

doi: 10.3760/cma.j.cn501120-20200914-00409

  • Department of Burns and Plastic Surgery, the 903th Hospital of the Joint Logistics Support Force of the People's Liberation Army, Hangzhou 310013, China

Funds:

Medicine and Health Technology Plan of Zhejiang Province of China 2018KY631

More Information
  • Corresponding author: Zhang Xudong, Email: wojiazhuhangzhou@hotmail.com
  • Received Date: 2020-09-14
    Abstract
  •     Objective   To investigate the effect of N-trimethyl chitosan-recombinant tissue factor pathway inhibitor (rTFPI) complex on avulsion flap with roll compaction in rat.    Methods   The experimental methods were adopted. The N-trimethyl chitosan-rTFPI complex solution was prepared by ion cross-linking method. The morphology of the complex was observed by scanning electron microscope, and its diameter was measured. The encapsulation rate of rTFPI in the complex and drug loading rate of the complex was determined and calculated by enzyme-linked immunosorbent assay (ELISA) method (n=3). The concentration of rTFPI in the solution at 0, 10, 30, 45, 60, 90, 120, 240 minutes of storage was measured by ELISA method to observe the release of rTFPI, and its half-life was calculated (n=3). Twenty-four 6-week-old male Sprague-Dawley rats were divided into phosphate buffered saline (PBS) group, N-trimethyl chitosan alone group, rTFPI alone group, and N-trimethyl chitosan-rTFPI group according to the random number table, with 6 rats in each group. The avulsion flaps with roll compaction were prepared on the backs of rats with pedicles located on the line of the bilateral iliac spine and lifted from the surface of the muscle membrane. One injection of corresponding reagents was carried out immediately after in-situ suture and on post operation day (POD) 1, 2, and 3. General changes of the flap were observed on POD 1, 3, and 7. On POD 7, the survival area of the flap was measured and the survival rate of the flap was calculated; the flaps were divided into pedicle, proximal, middle, and distal segments, and the blood perfusion in the proximal, middle, and distal segment tissue of the flap was detected by the laser speckle blood flow imager; tissue samples in the middle of the flap were cut and stained with hematoxylin and eosin to observe the changes in tissue structure and the infiltration of inflammatory cells, and the numbers of embolized blood vessels and new blood vessels per 100 times visual field were counted. Data were statistically analyzed with one-way analysis of variance and least significant difference test.    Results   The N-trimethyl chitosan-rTFPI complex had an irregular spherical structure with a diameter of 150-200 nm. The encapsulation rate of rTFPI in the complex and drug loading rate of the complex were (88.7±2.1)% and (2.83±0.09)%, respectively. The concentration of rTFPI in the solution of the N-trimethyl chitosan-rTFPI complex gradually increased with prolonged storage time, and the release was basically stable at 90 min, with half-life of (651±36) min. On POD 1, the distal parts of flaps of rats in N-trimethyl chitosan alone group darkened significantly. On POD 3, scabs and necrosis were relatively mild on the distal segment of the flaps of rats in rTFPI alone group and N-trimethyl chitosan-rTFPI group as compared with those of the other two groups. On POD 7, the necrosis boundaries of the flaps of rats in each group were clear. On POD 7, the flap survival rates of rats in rTFPI alone group and N-trimethyl chitosan-rTFPI group were (63±7)% and (73±5)%, respectively, which were significantly higher than (41±3)% in PBS group and (52±7)% in N-trimethyl chitosan alone group. Moreover, the flap survival rate of rats in N-trimethyl chitosan-rTFPI group was significantly higher than that in rTFPI alone group (P<0.05). On POD 7, the flaps of rats in each group had blood perfusion; the blood perfusion values in the proximal segment tissue of the rat flaps in N-trimethyl chitosan alone group and the blood perfusion values in the proximal, middle, and distal segment tissue of the rat flaps in rTFPI alone group and N-trimethyl chitosan-rTFPI group were significantly higher than those in PBS group (P<0.05 or P<0.01); the blood perfusion values in the distal segment tissue of the rat flaps in rTFPI alone group and the blood perfusion values in the middle and distal segment tissue of the rat flaps in N-trimethyl chitosan-rTFPI group were significantly higher than those in N-trimethyl chitosan alone group (P<0.05 or P<0.01); the blood perfusion value in the middle segment tissue of the rat flaps in N-trimethyl chitosan-rTFPI group was significantly higher than that in rTFPI alone group (P<0.01). On POD 7, inflammatory cells infiltrated more and cell edema was obvious in the middle segment tissue of the rat flaps in PBS group and N-trimethyl chitosan alone group. Compared with those of the previous two groups, the inflammation degrees in the middle segment tissue of the rat flaps in rTFPI alone group and N-trimethyl chitosan-rTFPI group were significantly milder, the number of embolized blood vessels was significantly decreased (P<0.05 or P<0.01), and the number of new blood vessels was significantly increased (P<0.05 or P<0.01). Compared with that of rTFPI alone group, the number of new blood vessels in the middle segment tissue of the rat flaps in N-trimethyl chitosan-rTFPI group increased significantly (P<0.05).    Conclusions   The effect of sustained release of rTFPI can be achieved by loading rTFPI with N-trimethyl chitosan. Compared with rTFPI alone, the N-trimethyl chitosan-rTFPI complex can further improve the blood perfusion of the avulsion flaps with roll compaction in rat and improve the survival rate of the flap.

     

    • FullText(HTML)
  • loading
    • References(36)
  • [1]
    McGowanSP, FallahiAKM. Degloving injuries[M]. Treasure Island (FL): StatPearls Publishing, 2020.
    [2]
    Boettcher-HaberzethS,SchiestlC.Management of avulsion injuries[J].Eur J Pediatr Surg,2013,23(5):359-364.DOI: 10.1055/s-0033-1353493.
    [3]
    郭杰皮肤撕脱伤撕脱皮瓣坏死机理的研究西安第四军医大学1997

    郭杰.皮肤撕脱伤撕脱皮瓣坏死机理的研究[D].西安:第四军医大学,1997.
    [4]
    EkstrandJ,RazuvaevA,FolkersenL,et al.Tissue factor pathway inhibitor-2 is induced by fluid shear stress in vascular smooth muscle cells and affects cell proliferation and survival[J].J Vasc Surg,2010,52(1):167-175.DOI: 10.1016/j.jvs.2010.02.282.
    [5]
    张旭东,吴近芳,茅东升,等.rTFPI在大鼠预防碾压撕脱皮瓣坏死中的应用[J].中华显微外科杂志,2016,39(4):359-362.DOI: 10.3760/cma.j.issn.1001-2036.2016.04.013.
    [6]
    余波,罗师平,宋丽萍,等.氨基酸序列突变对TFPI生物半衰期和生物活性的影响[J].生物化学与生物物理进展,2007,34(4):382-388.DOI: 10.3321/j.issn:1000-3282.2007.04.008.
    [7]
    BaiH,MaD,ZhangYG,et al.Molecular design and characterization of recombinant long half-life mutants of human tissue factor pathway inhibitor[J].Thromb Haemost,2005,93(6):1055-1060.DOI: 10.1160/TH04-11-0721.
    [8]
    KravanjaG,PrimožičM,KnezŽ,et al.Chitosan-based (Nano)materials for Novel Biomedical Applications[J].Molecules,2019,24(10):1960.DOI: 10.3390/molecules24101960.
    [9]
    ShariatiniaZ,JalaliAM.Chitosan-based hydrogels: preparation, properties and applications[J].Int J Biol Macromol,2018,115:194-220.DOI: 10.1016/j.ijbiomac.2018.04.034.
    [10]
    RizeqBR,YounesNN,RasoolK,et al.Synthesis, bioapplications, and toxicity evaluation of chitosan-based nanoparticles[J].Int J Mol Sci,2019,20(22):5776.DOI: 10.3390/ijms20225776.
    [11]
    DaiT,TanakaM,HuangYY,et al.Chitosan preparations for wounds and burns: antimicrobial and wound-healing effects[J].Expert Rev Anti Infect Ther,2011,9(7):857-879.DOI: 10.1586/eri.11.59.
    [12]
    HuY,ZhanC,ZhouA,et al.Synthesis and characterization of L-tyrosine-conjugated quaternary ammonium salt chitosan and their cytocompatibility as a potential tissue engineering scaffold[J].J Biomater Sci Polym Ed,2020,31(7):833-848.DOI: 10.1080/09205063.2020.1712174.
    [13]
    YiY,FeiJ,XuYX,et al.Preparation and characterization of a Schiff-based chitosan-fructose quaternary ammonium salt for medical applications[J].J Biomater Sci Polym Ed,2020,31(6):804-815.DOI: 10.1080/09205063.2020.1719684.
    [14]
    BognackiJ,HammelburgerJ.Functional and immunologic methods for the measurement of human tissue factor pathway inhibitor[J].Blood Coagul Fibrinolysis,1995,6 Suppl 1:S65-72.DOI: 10.1097/00001721-199506001-00011.
    [15]
    茅东升,张旭东,郑丽君,等.大鼠碾压撕脱皮瓣模型建立及皮瓣血运情况检测[J].中华烧伤杂志,2015,31(1):58-61.DOI: 10.3760/cma.j.issn.1009-2587.2015.01.015.
    [16]
    WangJ,TuoZ,ZhangJ,et al.Hyperoxygenated solution improves tissue viability in an avulsion injury flap model[J].J Plast Reconstr Aesthet Surg,2020,73(5):975-982.DOI: 10.1016/j.bjps.2019.11.029.
    [17]
    金文虎,周爱婷,吴中桓,等.血管内皮生长因子基因修饰人羊膜间充质干细胞利于超长随意皮瓣的成活[J].中国组织工程研究,2019,23(21):3349-3356.DOI: 10.3969/j.issn.2095-4344.1743.
    [18]
    XuP,WuY,ZhouL,et al.Platelet-rich plasma accelerates skin wound healing by promoting re-epithelialization[J/OL].Burns Trauma,2020,8:tkaa028[2020-09-14].https://pubmed.ncbi.nlm.nih.gov/32821743/.DOI: 10.1093/burnst/tkaa028.
    [19]
    李璐含,张秋菊,仉红刚,等.激光多普勒血流探测仪小波分析早期高血压大鼠血流灌注频谱特征[J].微循环学杂志,2019,29(2):1-7,13.DOI: 10.3969/j.issn.1005-1740.2019.02.001.
    [20]
    刘晓庆,仉红刚,张秋菊,等.高功率多普勒血流探测仪结合血流成像仪观察氯吡格雷对高血压大鼠微循环的影响?[J].微循环学杂志,2015,25(2):30-33.DOI: 10.3969/j.issn.1005-1740.2015.02.009.
    [21]
    SamsiS,JonesM,KepnerJ,et al.Colorization of H&E stained tissue using Deep Learning[J].Annu Int Conf IEEE Eng Med Biol Soc,2018,2018:640-643.DOI: 10.1109/EMBC.2018.8512419.
    [22]
    PowersDB,BreezeJ.Avulsive soft tissue injuries[J].Atlas Oral Maxillofac Surg Clin North Am,2019,27(2):135-142.DOI: 10.1016/j.cxom.2019.05.005.
    [23]
    宋坤修,马丙栋,刘永涛.吻合回流静脉对手部皮肤逆行撕脱伤成活的影响[J].实用手外科杂志,2018,32(1):100-101.DOI: 10.3969/j.issn.1671-2722.2018.01.034.
    [24]
    郭杰,鲁开化,郭树忠,等.皮肤撕脱伤撕脱皮瓣组织血管活性因子的变化及意义[J].1997,20(3):221-222.DOI: 10.3760/cma.j.issn.1001-2036.1997.03.131.
    [25]
    宋保强,郭树忠,鲁开化,等.皮肤撕脱伤中CD11b、ICAM-1动态表达的实验研究[J].中国美容医学杂志,2002,11(3):205-207.DOI: 10.3969/j.issn.1008-6455.2002.03.005.
    [26]
    LantieriLA,OzbekMR,DeuneEG,et al.Prevention of microvascular thrombosis by topical application of recombinant tissue factor pathway inhibitor[J].Plast Reconstr Surg,1996,97(3):587-594.DOI: 10.1097/00006534-199603000-00015.
    [27]
    吴耀强,陈宁,赖胜华,等.低分子肝素钙不同注射方式治疗带蒂皮瓣静脉危象的效果对比[J].中国当代医药,2018,25(30):48-50.DOI: 10.3969/j.issn.1674-4721.2018.30.016.
    [28]
    韩素琴,王欣,胡浩良,等.改良远端蒂腓动脉穿支螺旋桨皮瓣修复小腿及足踝部软组织缺损的围手术期护理[J].中华显微外科杂志,2018,41(2):201-202.DOI: 10.3760/cma.j.issn.1001-2036.2018.02.030.
    [29]
    荆文慧,荆洁.低分子量肝素钙所致不良反应文献概述[J].中国药物滥用防治杂志,2020,26(2):123-124.DOI: 10.15900/j.cnki.zylf1995.2020.02.013.
    [30]
    KhouriRK,ShermanR,BunckeHJ,et al.A phase Ⅱ trial of intraluminal irrigation with recombinant human tissue factor pathway inhibitor to prevent thrombosis in free flap surgery[J].Plast Reconstr Surg,2001,107(2):408-415; discussion 416-418.DOI: 10.1097/00006534-200102000-00016.
    [31]
    ChowdaryP.Anti-tissue factor pathway inhibitor (TFPI) therapy: a novel approach to the treatment of haemophilia[J].Int J Hematol,2020,111(1):42-50.DOI: 10.1007/s12185-018-2548-6.
    [32]
    AhnströmJ,GierulaM,TemenuJ,et al.Partial rescue of naturally occurring active site factor X variants through decreased inhibition by tissue factor pathway inhibitor and antithrombin[J].J Thromb Haemost,2020,18(1):136-150.DOI: 10.1111/jth.14627.
    [33]
    MaroneySA,HansenKG,MastAE.Cellular expression and biological activities of alternatively spliced forms of tissue factor pathway inhibitor[J].Curr Opin Hematol,2013,20(5):403-409.DOI: 10.1097/MOH.0b013e3283634412.
    [34]
    SantamariaS,Reglińska-MatveyevN,GierulaM,et al.Factor V has an anticoagulant cofactor activity that targets the early phase of coagulation[J].J Biol Chem,2017,292(22):9335-9344.DOI: 10.1074/jbc.M116.769570.
    [35]
    YehYC,HuangTH,YangSC,et al.Nano-based drug delivery or targeting to eradicate bacteria for infection mitigation: a review of recent advances[J].Front Chem,2020,8:286.DOI: 10.3389/fchem.2020.00286.
    [36]
    SongM,WangH,ChenK,et al.Oral insulin delivery by carboxymethyl-β-cyclodextrin-grafted chitosan nanoparticles for improving diabetic treatment[J].Artif Cells Nanomed Biotechnol,2018,46(Suppl 3):S774-782.DOI: 10.1080/21691401.2018.1511575.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(6)  / Tables(2)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (161) PDF downloads(21) Cited by()
    Proportional views
    Related

    Copyright © Chinese Journal of Burns京ICP备07035254号-14

    E-mail：shaoshangzazhi@163.com

    Website：https://zhsszz.xml-journal.net/

    Supported by: Beijing Renhe Information Technology Co. Ltd    

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return